Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

The effect of age in patients with acquired aplastic anaemia treated with immunosuppressive therapy: comparison of Adolescents and Young Adults with children and older adults.

Cabannes-Hamy A, Boissel N, Peffault De Latour R, Lengliné E, Leblanc T, de Fontbrune FS, Raffoux E, Robin M, Xhaard A, Baruchel A, Socié G, Dhédin N.

Br J Haematol. 2018 Dec;183(5):766-774. doi: 10.1111/bjh.15650. Epub 2018 Nov 8.

PMID:
30407615
2.

Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia.

Contejean A, Resche-Rigon M, Tamburini J, Alcantara M, Jardin F, Lengliné E, Adès L, Bouscary D, Marçais A, Lebon D, Chabrot C, Terriou L, Barraco F, Banos A, Bussot L, Cahn JY, Hirsch P, Maillard N, Simon L, Fornecker LM, Socié G, de Latour RP, de Fontbrune FS.

Haematologica. 2019 Feb;104(2):256-262. doi: 10.3324/haematol.2018.198440. Epub 2018 Sep 27.

3.

Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients.

Donadieu J, Lamant M, Fieschi C, de Fontbrune FS, Caye A, Ouachee M, Beaupain B, Bustamante J, Poirel HA, Isidor B, Van Den Neste E, Neel A, Nimubona S, Toutain F, Barlogis V, Schleinitz N, Leblanc T, Rohrlich P, Suarez F, Ranta D, Chahla WA, Bruno B, Terriou L, Francois S, Lioure B, Ahle G, Bachelerie F, Preudhomme C, Delabesse E, Cave H, Bellanné-Chantelot C, Pasquet M; French GATA2 study group.

Haematologica. 2018 Aug;103(8):1278-1287. doi: 10.3324/haematol.2017.181909. Epub 2018 May 3.

4.

Chronic graft versus host disease presenting as lichen planus pigmentosus.

Tétu P, Jachiet M, de Masson A, Hurabielle C, Rybojad M, Michonneau D, Battistella M, Rivet J, Peffault de Latour R, de Fontbrune FS, Bagot M, Socié G, Bouaziz JD.

Bone Marrow Transplant. 2018 Aug;53(8):1048-1050. doi: 10.1038/s41409-018-0110-z. Epub 2018 Feb 6. No abstract available.

PMID:
29410549
5.

Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centers.

Vallet N, de Fontbrune FS, Loschi M, Desmier D, Villate A, Barraco F, Chevallier P, Terriou L, Yakoub-Agha I, Ruggeri A, Mohty M, Maillard N, Rohrlich PS, Ceballos P, Nguyen S, Poiré X, Guillerm G, Tabrizi R, Farhi J, Devillier R, Rubio MT, Socié G, de Latour RP; Société Francophone de Greffe de Moelle et Thérapie Cellulaire.

Haematologica. 2018 Mar;103(3):e103-e105. doi: 10.3324/haematol.2017.182360. Epub 2017 Dec 21. No abstract available.

6.

Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia.

Lengline E, Drenou B, Peterlin P, Tournilhac O, Abraham J, Berceanu A, Dupriez B, Guillerm G, Raffoux E, de Fontbrune FS, Ades L, Balsat M, Chaoui D, Coppo P, Corm S, Leblanc T, Maillard N, Terriou L, Socié G, de Latour RP.

Haematologica. 2018 Feb;103(2):212-220. doi: 10.3324/haematol.2017.176339. Epub 2017 Nov 23.

7.

Combined intensive immunosuppression and eculizumab for aplastic anemia in the context of hemolytic paroxysmal nocturnal hemoglobinuria: a retrospective analysis.

Pagliuca S, Risitano AM, De Fontbrune FS, Robin M, Iori AP, Marotta S, Michonneau D, Villate A, Desmier D, Socié G, De Latour RP.

Bone Marrow Transplant. 2018 Jan;53(1):105-107. doi: 10.1038/bmt.2017.220. Epub 2017 Nov 13. No abstract available.

PMID:
29131151
8.

Immunothérapie et greffe de cellules souches hématopoïétiques allogéniques.

de Fontbrune FS, Cavalieri D, Leclerc M, Beckerich F, Maury S, de Latour RP, N-Guyen S, Bay JO.

Bull Cancer. 2016 Nov;103 Suppl 1:S164-S174. doi: 10.1016/S0007-4551(16)30375-7. French. Erratum in: Bull Cancer. 2017 May;104(5):494.

PMID:
28057181
9.

A case of BK virus nephropathy without hemorrhagic cystitis after hematopoietic stem cell transplantation.

Burbach M, Birsen R, Denis B, Munier AL, Verine J, de Fontbrune FS, Peraldi MN.

Ann Hematol. 2016 Sep;95(9):1567-8. doi: 10.1007/s00277-016-2725-8. Epub 2016 Jun 9. No abstract available.

PMID:
27278550
10.

Usefulness of daily surveillance blood cultures in allogeneic hematopoietic stem cell transplant recipients on steroids: a 1-year prospective study.

Colombier MA, Lafaurie M, de Fontbrune FS, Resche-Rigon M, Donay JL, Pons JL, Molina JM, Socie G.

Transpl Infect Dis. 2016 Aug;18(4):504-11. doi: 10.1111/tid.12552. Epub 2016 Aug 1.

PMID:
27218243
11.

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.

Mehta RS, Peffault de Latour R, DeFor TE, Robin M, Lazaryan A, Xhaard A, Bejanyan N, de Fontbrune FS, Arora M, Brunstein CG, Blazar BR, Weisdorf DJ, MacMillan ML, Socie G, Holtan SG.

Haematologica. 2016 Jun;101(6):764-72. doi: 10.3324/haematol.2015.138990. Epub 2016 Apr 1.

12.

APRIL levels are associated with disease activity in human chronic graft-versus-host disease.

Chasset F, de Masson A, Le Buanec H, Xhaard A, de Fontbrune FS, Robin M, Rybojad M, Parquet N, Brignier AC, Coman T, Bengoufa D, Bergeron A, Peffault de Latour R, Bagot M, Bensussan A, Socié G, Bouaziz JD.

Haematologica. 2016 Jul;101(7):e312-5. doi: 10.3324/haematol.2016.145409. Epub 2016 Mar 18. No abstract available.

13.

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey.

Zeiser R, Burchert A, Lengerke C, Verbeek M, Maas-Bauer K, Metzelder SK, Spoerl S, Ditschkowski M, Ecsedi M, Sockel K, Ayuk F, Ajib S, de Fontbrune FS, Na IK, Penter L, Holtick U, Wolf D, Schuler E, Meyer E, Apostolova P, Bertz H, Marks R, Lübbert M, Wäsch R, Scheid C, Stölzel F, Ordemann R, Bug G, Kobbe G, Negrin R, Brune M, Spyridonidis A, Schmitt-Gräff A, van der Velden W, Huls G, Mielke S, Grigoleit GU, Kuball J, Flynn R, Ihorst G, Du J, Blazar BR, Arnold R, Kröger N, Passweg J, Halter J, Socié G, Beelen D, Peschel C, Neubauer A, Finke J, Duyster J, von Bubnoff N.

Leukemia. 2015 Oct;29(10):2062-8. doi: 10.1038/leu.2015.212. Epub 2015 Jul 31.

14.

Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC.

de Fontbrune FS, Galambrun C, Sirvent A, Huynh A, Faguer S, Nguyen S, Bay JO, Neven B, Moussi J, Simon L, Xhaard A, Resche-Riggon M, O'Meara A, Fremeaux-Bacchi V, Veyradier A, Socié G, Coppo P, de Latour RP.

Transplantation. 2015 Sep;99(9):1953-9. doi: 10.1097/TP.0000000000000601.

PMID:
25651309
15.

Late donor bone marrow failure after allogeneic hematopoietic stem cell transplantation.

Meunier M, Manez AC, Xhaard A, Peffault de Latour R, de Fontbrune FS, Dhedin N, Socié G, Robin M.

Transplantation. 2014 Jun 27;97(12):e75-7. doi: 10.1097/TP.0000000000000177. No abstract available.

PMID:
24933256
16.

Iterative breakthrough invasive aspergillosis due to TR(34) /L98H azole-resistant Aspergillus fumigatus and Emericella sublata in a single hematopoietic stem cell transplant patient.

de Fontbrune FS, Denis B, Meunier M, Garcia-Hermoso D, Bretagne S, Alanio A.

Transpl Infect Dis. 2014 Aug;16(4):687-91. doi: 10.1111/tid.12231. Epub 2014 May 10.

PMID:
24816170
17.

Viral respiratory infections diagnosed by multiplex PCR after allogeneic hematopoietic stem cell transplantation: long-term incidence and outcome.

Wolfromm A, Porcher R, Legoff J, Peffault de Latour R, Xhaard A, de Fontbrune FS, Ribaud P, Bergeron A, Socié G, Robin M.

Biol Blood Marrow Transplant. 2014 Aug;20(8):1238-41. doi: 10.1016/j.bbmt.2014.04.004. Epub 2014 Apr 13.

18.

Autoimmune neutropenia after kidney transplantation: a disregarded entity of posttransplant neutropenia.

Aubert O, Sberro-Soussan R, Scemla A, Casadevall N, Teyssandier I, Martinez F, Hermine O, Legendre C, Varet B, De Fontbrune FS.

Transplantation. 2014 Apr 15;97(7):725-9. doi: 10.1097/TP.0000000000000109.

PMID:
24598937
19.

Broad-range PCR-electrospray ionization mass spectrometry for detection and typing of adenovirus and other opportunistic viruses in stem cell transplant patients.

Legoff J, Feghoul L, Mercier-Delarue S, Dalle JH, Scieux C, Chérot J, de Fontbrune FS, Baruchel A, Socié G, Simon F.

J Clin Microbiol. 2013 Dec;51(12):4186-92. doi: 10.1128/JCM.01978-13. Epub 2013 Oct 9.

20.

Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation.

de Fontbrune FS, Robin M, Porcher R, Scieux C, de Latour RP, Ferry C, Rocha V, Boudjedir K, Devergie A, Bergeron A, Gluckman E, Azoulay E, Lapalu J, Socié G, Ribaud P.

Clin Infect Dis. 2007 Oct 15;45(8):1019-24. Epub 2007 Sep 11.

PMID:
17879919
21.

Veno-occlusive disease of the liver after lung transplantation.

de Fontbrune FS, Mal H, Dauriat G, Brugière O, Biondi G, Taillé C, Valla D, Castier Y, Fournier M.

Am J Transplant. 2007 Sep;7(9):2208-11.

22.

[Adenosine deaminase is useful for the diagnosis of peritoneal tuberculosis in patients with end-stage renal failure].

Gobert D, Lidove O, de Fontbrune FS, Peltier J, Chedid K, Burnat P, Perrier F, Chauveheid MP, Papo T.

Rev Med Interne. 2007 Jul;28(7):507-9. Epub 2007 Mar 13. French.

PMID:
17397971

Supplemental Content

Loading ...
Support Center